The U.S. Food and Drug Administration (FDA) has approved GSK’s Blujepa (gepotidacin), a groundbreaking oral antibiotic for ...
A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...
Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes.
The Food and Drug Administration has approved a new antibiotic that can treat uncomplicated urinary tract infections, or ...
3d
Everyday Health on MSNNew UTI Antibiotic Is the First Approved by the FDA in Nearly 30 YearsKey TakeawaysBlujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial ...
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...
Blujepa is the first in a new class of oral antibiotics in 30 years. It is expected to launch in the second half of 2025 in the United States.
A new antibiotic has been approved to treat urinary tract infections by the Food and Drug Administration for the first time ...
The U.S. Food and Drug Administration (FDA) has approved a new class of antibiotics for treating uncomplicated urinary tract ...
GSK's pill, the first oral antibiotic for urinary tract infections in almost 30 years, comes as bacteria are increasingly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results